An Open-label, Multicenter, Single-group Study to Evaluate the Effects of Long-term Use of Mucinex® in Patients With Stable Chronic Bronchitis.
This is an open-label, multicenter, single-group study designed to determine the effectiveness of Mucinex® when used by patients to treat SCB over a 12-week period, following a 2-week run-in period of no treatment (to establish a baseline).
100 项与 American Health Research, LLC 相关的临床结果
0 项与 American Health Research, LLC 相关的专利(医药)
100 项与 American Health Research, LLC 相关的药物交易
100 项与 American Health Research, LLC 相关的转化医学